ASML’s EUV Monopoly Powers the Global AI Chip Boom 
Ryanair Profit Slumps in Q3 After Italy Antitrust Fine Despite Revenue Growth 
UK Politicians Call for Full Competition Review of Netflix’s Warner Bros Discovery Deal 
Microsoft Wins Approval to Build 15 New Data Centers in Wisconsin 
Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025 
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive 
Baker Hughes Reports 11% Rise in Q4 Adjusted Profit Driven by LNG Demand 
Trump Administration Takes Stake in USA Rare Earth to Boost U.S. Critical Minerals Supply 
Alibaba-Backed Moonshot AI Unveils Kimi K2.5 to Challenge China’s AI Rivals 
Noble Corporation Secures $1.3 Billion in New Contracts, Strengthening Offshore Drilling Backlog 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges 
ANTA Sports to Acquire Major Stake in Puma in €1.5 Billion Deal, Signaling Strategic Revival 
Ford and GM Near Financing Deal to Support First Brands Group During Bankruptcy 
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House 
BETHLEHEM, Pa., May 16, 2017 -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS Global Healthcare Conference in New York, New York. The conference will be simultaneously webcast over the Internet.
Mr. Michels is scheduled to speak on May 23, 2017, at approximately 8:30 AM Eastern Time (5:30 AM Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com, and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for seven days. Alternatively, you can access the live webcast of the presentation via the following link: https://cc.talkpoint.com/ubsx001/052217a_as/?entity=37_J1YMCU8.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market, innovative products include rapid tests for the detection of antibodies to HIV and HCV on the OraQuick® platform, oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications, and oral fluid laboratory tests for detecting various drugs of abuse. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, commercial and industrial entities and consumers. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health. For more information on OraSure Technologies, please visit www.orasure.com.
Company contact: Ronald H. Spair Chief Financial Officer 610-882-1820 [email protected] www.orasure.com Shauna White Corporate Marketing Manager 484-353-1575 [email protected] www.orasure.com
